药师主导的2型糖尿病小组医疗访视的成本与效果：多中心随机对照试验

数据集获取（Figshare）

• 源站标题：Costs and effectiveness of pharmacist-led group medical visits for type-2 diabetes: A multi-center randomized controlled trial
• DOI：10.1371/journal.pone.0195898
• 发布日期：2018-04-19
• 文件数：2 个
• 文件总体积：422.44 KB
• 源站页面：https://plos.figshare.com/articles/dataset/Costs_and_effectiveness_of_pharmacist-led_group_medical_visits_for_type-2_diabetes_A_multi-center_randomized_controlled_trial/6161969

命令行下载

curl -L -o "S1 Table.pdf" "https://ndownloader.figshare.com/files/11149550"
curl -L -o "S1 Text.pdf" "https://ndownloader.figshare.com/files/11149559"

文件清单

• S1 Table.pdf（105.24 KB）
• S1 Text.pdf（317.20 KB）

文件总体积 422.44 KB（源站 API 实测）。

数据加载示例（图像类）

from PIL import Image
import glob, os

files = (glob.glob(os.path.join(path, "**", "*.png"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.jpg"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.tif"), recursive=True))
print("图像文件数:", len(files))
img = Image.open(files[0]); print("尺寸/模式:", img.size, img.mode)

# torchvision Dataset 方式:
# from torchvision import datasets
# ds = datasets.ImageFolder(path)  # 要求 子目录=类别

目录组织与标注格式以源站说明和下载后实际文件为准。

数据说明

Objectives
The effectiveness and costs associated with addition of pharmacist-led group medical visits to standard care for patients with Type-2 Diabetes Mellitus (T2DM) is unknown.
Methods
Randomized-controlled-trial in three US Veteran Health Administration (VHA) Hospitals, where 250 patients with T2DM, HbA1c >7% and either hypertension, active smoking or hyperlipidemia were randomized to either (1) addition of pharmacist-led group-medical-visits or (2) standard care alone for 13 months. Group (4–6 patients) visits consisted of 2-hour, education and comprehensive medication management sessions once weekly for 4 weeks, followed by quarterly visits. Change from baseline in cardiovascular risk estimated by the UKPDS-risk-score, health-related quality-of-life (SF36v) and institutional healthcare costs were compared between study arms.
Results
After 13 months, both groups had similar and significant improvements from baseline in UKPDS-risk-score (-0.02 ±0.09 and -0.04 ±0.09, group visit and standard care respectively, adjusted pConclusions
Addition of pharmacist-led group medical visits in T2DM achieved similar improvements from baseline in cardiovascular risk factors than usual care, but with reduction in the healthcare costs in the group visit arm 13 months after completion compared to the steady rise in cost for the usual care arm.
Trial registration
NCT00554671 ClinicalTrials.gov

许可

CC BY 4.0

引用

学术使用请引用 DOI 10.1371/journal.pone.0195898（source: https://plos.figshare.com/articles/dataset/Costs_and_effectiveness_of_pharmacist-led_group_medical_visits_for_type-2_diabetes_A_multi-center_randomized_controlled_trial/6161969）。